Research & Development

狠狠干视频狠狠干在线影院青青草在线视频在线陌生人突袭新潮能源要罢免董事长 德隆系卷土重来?


  他們甚至聰明到拉著同樣跟煤炭有利益關聯的煤炭商一起出錢來修建索道,如果有煤炭商不肯出錢支持,他們就一起決定不賣煤炭給那個商賈。   即便不會為難你,也會迅速的疏遠你,這樣的事情根本不以個人意志力轉移。狠狠干视频   狗子哈哈大笑道︰“我家主人常說,子非魚,焉知魚之樂!”狠狠干在线影院   各地的藩王也非常的害怕……   雲瑯笑道︰“我西北理工也湊一手如何?”青青草在线视频在线   先下手為強!

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo